Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Applied Therapeutics Inc Announces Upsizing And Pricing Of Public Offering Of 2 741 489 Shares Of Common Stock is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
--(BUSINESS WIRE)-- Stoke Therapeutics, Inc. (Nasdaq ... today announced the pricing of its upsized underwritten public offering of 5,555,557 shares of its common stock at a price to the public ... Read More
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an upsized underwritten public offering of 8,520,000 shares of its common stock at a ... Read More
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
March 05, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq ... announced today the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a public offering ... Read More
Contineum Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Contineum Therapeutics, Inc. (Contineum), a clinical ... today announced the pricing of its initial public offering of 6,875,000 shares of its Class A ... Read More
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking ... announced the pricing of its underwritten public offering of 6,471,000 shares of its common stock at a price ... Read More
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq ... today announced the pricing of an underwritten public offering of 4,440,851 shares of its common stock at a public offering ... Read More
Jasper Therapeutics Announces Offering Pricing Details
Jasper Therapeutics (JSPR) has released an update. The Company has publicly announced the pricing details of its Offering on February 6, 2024, through a press release. This information is crucial ... Read More
ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
Feb. 29, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq ... announced today the pricing of its underwritten public offering of 2,307,694 shares of its common stock at a price to the ... Read More
Contineum Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Contineum Therapeutics, Inc. (Contineum ... the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus